21.20.Z - Manufacture of medicines and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical substances
46.46.Z - Wholesale of pharmaceutical goods
49.41.Z - Freight transport by road
52.10.B - Warehousing and storage of other goods
53.20.Z - Other postal and courier activities
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
82.92.Z - Packaging activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
2017 | 2018 | 2019 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | -0 | -0,1 | -215,6 |
EBITDA | -0 | -0,1 | -301,1 | |
Short time liabilities | 1,1 | 0,9 | -15,8 | |
Income tax | 0 | |||
Equity capital | -0,6 | -0,6 | -0,7 | -18,2 |
Operating profit (EBIT) | -0 | -0,1 | -301,1 | |
Assets | 1,1 | 0,7 | 0,3 | -49,5 |
Net profit (loss) | -0,3 | -0 | -0,1 | -215,6 |
Cash | 0 | 0 | -92,5 | |
Net income from sale | 0,5 | 0,3 | -46,3 | |
Liabilities and provisions for liabilities | 1,6 | 1,3 | 1 | -18,1 |
Working assets | 1 | 0,6 | 0,2 | -58,3 |
Depreciation | 0 | 0 | 0 | |
Basic operational activity income | 1,3 | |||
% | % | % | p.p. | |
Profitability of capital | 5,8 | 15,4 | 9,6 | |
Equity capital to total assets | -51 | -86,2 | -201,7 | -115,5 |
Gross profit margin | -19,9 | -6,3 | -37,3 | -31 |
EBITDA Margin | -4,4 | -32,6 | -28,2 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 761 | 1192 | 431 | |
Current financial liquidity indicator | 0.518867015838623 | 0.25711140036582947 | -0,2 | |
Net dept to EBITDA | -21.652189254760742 | -3.244745969772339 | 18,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane